Menu

HHS Building exterior.

The Centers for Medicare and Medicaid Services has proposed new models to test alternative methods for calculating inflation rebates for certain Medicare Part B and Part D drugs.

CMS Proposals Requiring Drugmakers to Pay Additional Rebates on Medicare Drugs Could Affect 340B Ceiling Prices

January 13, 2026 Shannon Young, Associate Editor/Senior Writer 340B Report Views

Two proposed federal rules requiring drug manufacturers to pay new rebates to the Medicare Trust Fund if prices for certain [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

A View from Washington D.C. and the States — 340B Current Issues and Outlook

340B Rebate Debate Far From Over After HHS Moves to Drop Appeal of Rebate Pilot Ruling, Attorneys Say